Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Quince Therapeutics, Inc. (Nasdaq: QNCX) will present at The Citizens JMP Life Sciences Conference to discuss their innovative drug delivery technology for rare diseases. The presentation by Quince's CEO and CMO will be available via live webcast on May 13, 2024.
- None.
- None.
A live webcast of the presentation will be accessible on the Events page under the News & Events heading of Quince’s Investor Relations website at ir.quincetx.com. An archive of the webcast will be available shortly following the end of the live event.
About Quince Therapeutics
Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the potential of a patient’s own biology to deliver innovative and life-changing therapeutics to those living with rare diseases. For more information on the company and its latest news, visit www.quincetx.com and follow Quince Therapeutics on social media platforms LinkedIn, Facebook, and Twitter/X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240506671205/en/
Media & Investor Contact:
Stacy Roughan
Quince Therapeutics, Inc.
Vice President, Corporate Communications & Investor Relations
ir@quincetx.com
Source: Quince Therapeutics, Inc.
FAQ
When will Quince Therapeutics present at The Citizens JMP Life Sciences Conference?
Where can I watch the presentation by Quince Therapeutics?